Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Analyst Color

Analyst Color

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Initiation
  • Movers
  • News
  • Price Target
  • Small Cap
  • Trading Ideas

With Upcoming Ovarian Cancer Data, Analyst Sees 100% Upside For Mersana Therapeutics

By Vandana Singh
January 20, 4:16 PM
Citi initiated coverage on Mersana Therapeutics Inc (NASDAQ:MRSN) with a Buy rating and a price target of $12.  The analyst says the…

MKKGY

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • General
  • News
  • Price Target
  • Reiteration

Fastenal’s Q4 Beat Fueled By Opex Leverage, Says Analyst Who Struggles To ‘Get The Math To Work’

By Shivani Kumaresan
January 20, 3:37 PM
Raymond James analyst Sam J. Darkatsh reiterated an Underperform rating on the shares of Fastenal Co (NASDAQ: FAST).

FAST

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Initiation
  • Movers
  • News
  • Price Target
  • Trading Ideas

Noting Strong Progress On Marinus Pharma’s Lead Drug Ganaxolone, Analyst Initiates With 300% Upside

By Vandana Singh
January 20, 3:17 PM
RBC Capital Markets initiated coverage on Marinus Pharmaceuticals Inc (NASDAQ:MRNS) with an Outperform rating, Speculative Risk, and a price target of…

MRNS

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

Analysts See PPG’s Price, Cost Tailwinds Driving Margins With Additional Tailwinds From Auto Business Post 4Q Beat

By Anusuya Lahiri
January 20, 2:48 PM
BMO Capital analyst John P. McNulty had an Outperform on PPG Industries, Inc (NYSE:PPG) with a $151.00 price target. PPG posted a solid…

AXTI

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • General
  • Health Care
  • News
  • Price Target
  • Reiteration

Exelixis’ Patent Decision In Line With Expectations, But Analysts Say Stock Overhang Could Continue

By Vandana Singh
January 20, 2:17 PM
Exelixis Inc (NASDAQ:EXEL) announced that the U.S. District Court for the District of Delaware ruled in its favor, rejecting MSN…

EXEL

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • General
  • Initiation
  • News
  • Price Target

KeyBanc Initiates Coverage On Wayfair Amid Weakening Consumer Spending

By Shivani Kumaresan
January 20, 2:00 PM
KeyBanc analyst Bradley Thomas initiated coverage on Wayfair Inc (NYSE:W) with a Sector Weight rating. The analyst said Wayfair, and the furniture…

W

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

T-Mobile US’ Lower Churn Likely To Drive Future Performance: Analyst

By Anusuya Lahiri
January 20, 1:43 PM
Citi analyst Michael Rollins reiterated a Buy rating on T-Mobile US, Inc (NASDAQ:TMUS) and raised the price target from $172 to $174.…

TMUS

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target
  • Tech

Lack Of E-Commerce Visibility Leads To Squarespace Downgrade, Analyst Says

By Anusuya Lahiri
January 20, 1:26 PM
KeyBanc analyst Josh Beck downgraded Squarespace, Inc (NYSE:SQSP) to Sector Weight from Overweight without a price target. The re-rating reflected a more…

AMZN

Read More
4 minute read
  • Analyst Color
  • Analyst Ratings
  • Entertainment
  • General
  • Media
  • Price Target
  • Reiteration
  • Top Stories
  • Trading Ideas

Netflix Analysts Are Raising Price Targets After Q4 Beat, Even The Ones With Sell And Neutral Ratings: Here’s Why

By Chris Katje
January 20, 1:15 PM
Streaming giant Netflix Inc (NASDAQ: NFLX) reported fourth-quarter financial results that saw revenue come in ahead of analysts’ estimate

NFLX

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Price Target
  • Tech
  • Upgrades

PagerDuty’s Market Leadership Will Help It Sustain 20% Growth Amid Macro Headwinds, Analyst Says

By Anusuya Lahiri
January 20, 1:05 PM
Morgan Stanley analyst Sanjit Singh upgraded PagerDuty Inc (NYSE:PD) from Equal-Weight to Overweight and raised the price target from $32 to $36.…

PD

Posts navigation

Previous 1 … 40 41 42 … 494 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service